Project: FRIDASTEM: A novel drug discovery platform delivering breakthrough cancer stem cell (CSC) drugs

FRIDASTEM aims at building a novel platform for screening fragments and small molecule libraries against unexplored CSC-specific GPCRs and kinases involved in CSC proliferation, migration and invasion. The platform will be offered for screening services after validation: by using known inhibitors and by identifying new molecular entities (NME) with anticancer properties. Selected hits will be optimized towards early leads. At least one lead will be chosen to for further preclinical development.

Acronym	FRIDASTEM (Reference Number: 9723)
Duration	01/10/2015 - 01/10/2018
Project Topic	Biological Sciences / Technologies
Network	Eurostars 2
Call	Eurostars Cut-Off 3

Project partner

Number	Name	Role	Country
21445	Canvax Biotech	Coordinator	Spain
21446	Villapharma Research	Partner	Spain
21447	Proteros biostructures GmbH	Partner	Germany